B60.00
Babesiosis, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Babesiosis due to unspecified Babesia species
- Piroplasmosis, unspecified
Medical Intelligence & Overview
Babesiosis is a parasitic infection caused by microscopic protozoa of the genus Babesia. This disease primarily affects red blood cells and can lead to a range of health issues. When the specific species of Babesia causing the infection is not identified, it is classified as 'Babesiosis, unspecified' under ICD-10 code B60.00. While it is more common in certain geographic regions, especially areas with tick populations, babesiosis is a significant concern due to its potential severity if left untreated. Understanding its causes, symptoms, and treatment options can help in managing this disease effectively.
Causes & Symptoms
Clinical Causes: Transmission primarily occurs through the bite of infected ticks, particularly the Ixodes species. Blood transfusions from an infected donor can also transmit the parasite. Rarely, congenital transmission from mother to fetus occurs during pregnancy. Infection spread is more prevalent in areas where ticks carrying Babesia are common, such as parts of the Northeastern and Midwestern United States, and certain regions in Europe and Asia.
Key Symptoms: Fever and chills Sweating Fatigue and weakness Muscle aches and joint pain Headaches Loss of appetite Nausea or vomiting Dark urine (indicating breakdown of red blood cells) In severe cases, symptoms may include anemia, jaundice, and organ failure.
Diagnostic & Treatment
Diagnosis Path: Blood tests are essential for detecting Babesia parasites, including microscopic examination of blood smears. Polymerase chain reaction (PCR) testing can identify Babesia DNA for more precise diagnosis. Serologic tests to detect specific antibodies may help determine recent or past infection. Complete blood count (CBC) often shows anemia and other abnormalities related to red blood cell destruction.
Treatment Protocols: The primary treatment involves a combination of antimicrobial medications such as atovaquone and azithromycin for mild cases. For severe infections, additional drugs like clindamycin with quinine may be recommended. Supportive care, including blood transfusions, may be necessary in cases of significant anemia. Monitoring and follow-up are crucial to ensure the infection clears completely and to manage any complications.
Clinical Advice & FAQs
Billing Guidance
Is B60.00 a billable ICD-10 code?
Yes, B60.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B60.00?
Clinical documentation must specify the nature of Babesiosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference